Active ingredient
Latanoprostene Bunod
3 finished FDA listings contain Latanoprostene Bunod as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- LATANOPROSTENE BUNOD
- Dosage forms
- Solution/ Drops
- Routes
- Ophthalmic
- Manufacturers / labelers
- 2
- Strengths listed
- .24 mg/ml
- Brand names in FDA listings
- Vyzulta
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1988390
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 207795 | BAUSCH AND LOMB | 2017-11-02 | 1 |
| ANDA 217387 | GLAND | 2025-04-29 | 2 |
Official labeling on DailyMed
- LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024% SOLUTION/ DROPS [GLAND PHARMA LIMITED] · version 6 · 2025-05-05
- VYZULTA (LATANOPROSTENE BUNOD) SOLUTION/ DROPS [BAUSCH & LOMB INCORPORATED] · version 7 · 2024-02-29
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.